New test could spot rare genetic disorders earlier
NCT ID NCT04201067
Summary
This study aimed to see if a new, broad metabolomic testing method could better diagnose rare inborn errors of metabolism than older tests. Researchers analyzed leftover samples from 240 people with these genetic conditions. The goal was to find better biomarkers to help identify these disorders and potentially track how well treatments work.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL DISORDERS OF GLYCOSYLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.